HOOKIPA PHARMA INC. [FORM OF] OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [ ] by and between Hookipa Pharma Inc., a Delaware corporation (the “Company”), and [Officer] (“Indemnitee”).(1)
HOOKIPA PHARMA INC. [FORM OF] DIRECTOR INDEMNIFICATION AGREEMENTDirector Indemnification Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [ ] by and between HOOKIPA Pharma Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).
RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN GILEAD SCIENCES, INC. AND HOOKIPA BIOTECH AGResearch Collaboration and License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • New York
This RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is made as of June 4, 2018 (the “Effective Date”), by and between Gilead Sciences, Inc., a Delaware corporation having an office at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”) and Hookipa Biotech AG, an Austrian corporation (Aktiengesellschaft) having an office at St Marx Vienna Bio Center: Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“Hookipa”). Gilead and Hookipa are each referred to individually as a “Party” and together as the “Parties.”
CONSULTANCY AGREEMENTConsultancy Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
ContractExclusive License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
ContractExclusive License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
RENTAL AGREEMENT Partial application area OfficeRental Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Concluded between: Wüstenrot Marxbox GmbH & Co KG Alpenstraße 61, 5033 Salzburg FN 346428d represented by ÖRAG - Österreichische Realitäten 1010 Vienna, Herrengasse 17, as the Property Manager
ContractLicense Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTLicense Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • District of Columbia
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A. and Hookipa Biotech AG (“Licensee”), a corporation of Vienna, Austria, having an office at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria.
Funding Contract concluded between The Austrian Research Promotion Agency (FFG) as Funding Agency and HOOKIPA Biotech AG Mariahilfer Straße 123/3. Stock 1060 Vienna Commercial register no. FN 365895g as Funding Recipient. Sec. 1 Granting fundsHOOKIPA Pharma Inc. • March 22nd, 2019 • Pharmaceutical preparations
Funding Contract concluded between The Austrian Research Promotion Agency (FFG) as Funding Agency and HOOKIPA Biotech AG Helmut-Qualtinger-Gasse 2 1030 Vienna Commercial register no. FN 365895g as Funding Recipient. Sec. 1 Granting fundsHOOKIPA Pharma Inc. • March 22nd, 2019 • Pharmaceutical preparations
RENTAL AGREEMENT Partial scope OfficeRental Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
